Professor Sun Jia's team from the School of Food Science and Technology of Jiangnan University published a research paper on EMBO Molecular Medicine

Recently, Professor Sun Jia’s team from the School of Food Science and Technology of Jiangnan University has made important progress in the treatment of celiac disease with the intestinal flora-antibacterial peptide CRAMP axis.

In addition to antibacterial activity, intestinal cathelicidin-related antimicrobial peptides (CRAMP) have immunomodulatory functions that have not yet been revealed.

Figure 1.

This work was carried out by the team of Professor Sun Jia from the School of Food Science and Technology of Jiangnan University in cooperation with Jiangnan University School of Medicine, Nanchang University, Yifu Hospital Affiliated to Nanjing Medical University, Institute of Microbiology, Chinese Academy of Sciences, Karolinska Institutet of Sweden, and French National Institute of Health and Medicine The completion of the cooperation

Professor Sun Jia has long been engaged in the intervention of endogenous active substances and immune regulation of the body and related major diseases.

This work was supported by the National Natural Science Foundation Major Research Program Cultivation Project, the Jiangsu Natural Science Foundation Outstanding Youth Project, the Jiangsu Double Innovation Project Team Leading Talent Project, and the National First-Class Discipline Construction of Food Science and Engineering